WHO estimates that in 2015, 257 million people were living with chronic hepatitis B
virus (HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly
as a result of cirrhosis or hepatocellular carcinoma. Most HBV-associated deaths among
adults are secondary to infections acquired at b...
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive th...
The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. The following recommendations are based on systematic reviews of scientific evidence, community values and preferences and implementation i...
Medical treatment is intended to save life and improve health, and all health workers have a responsibility to prevent transmission of health-care associated infections. Adherence to safe injection practices and related infection control is part of that responsibility it protects patients and health work...
